P3 Health Partners (PIII) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue rose 15% year-over-year to $379.2 million, driven by 23% growth in at-risk members to 128,100 and expansion into new counties, with a capital-light, scalable model in a $1 trillion addressable market.

• The platform operates with 2,900 PCPs across five states, focusing on Medicare Advantage and expanding its affiliate network.

• Diversified payer mix, with no single payer exceeding 20% of revenue, and strong relationships with payers and independent primary care groups.

• Initiatives underway to improve Star Ratings, close care quality gaps, enhance chronic disease management, and target sustainable profitability.

• Smart growth strategy prioritizes increasing member density within existing PCPs and operational efficiency.

Financial highlights

• Capitated revenue for Q2 2024 was $374.3 million, up 15% year-over-year; total revenue reached $379.2 million.

• Medical margin for Q2 2024 was $41.1 million ($107 PMPM), down from $50.5 million, with a 6% sequential improvement in medical cost ratio.

• Adjusted EBITDA loss for Q2 was $8.8 million ($23 PMPM), a 50% improvement quarter-over-quarter but down from a $0.2 million gain in Q2 2023.

• Gross profit for Q2 2024 was $14.0 million, down from $26.8 million in Q2 2023.

• Operating expenses decreased 14% year-over-year, now 6% of revenue; platform support costs were 5.3% of total operating revenue.

Outlook and guidance

• 2024 guidance: at-risk membership 125,000–135,000, revenue $1.45–$1.55 billion, medical margin $230–$250 million ($165–$175 PMPM), and Adjusted EBITDA $20–$40 million.

• Confident in guidance due to revenue recognition from final sweeps, ongoing medical cost management, and additional cost efficiency initiatives, but management cautions actual results may differ materially due to risk factors.

• The company expects continued operating losses and negative cash flows as it invests in growth and expands its member base.

• Management is exploring additional capital raising through debt and equity to support operations and growth.